13-cyclohexyl-N-[2-[6-(dimethylcarbamoyl)-1H-benzimidazol-2-yl]propan-2-yl]-3-methoxy-6,7-dihydroindolo[1,2-d][1,4]benzoxazepine-10-carboxamide;2-[2-[(13-cyclohexyl-3-methoxy-6,7-dihydroindolo[1,2-d][1,4]benzoxazepine-10-carbonyl)amino]propan-2-yl]-3H-benzimidazole-5-carboxylic acid

C72H77N9O9 — CID 162220244

IUPAC13-cyclohexyl-N-[2-[6-(dimethylcarbamoyl)-1H-benzimidazol-2-yl]propan-2-yl]-3-methoxy-6,7-dihydroindolo[1,2-d][1,4]benzoxazepine-10-carboxamide;2-[2-[(13-cyclohexyl-3-methoxy-6,7-dihydroindolo[1,2-d][1,4]benzoxazepine-10-carbonyl)amino]propan-2-yl]-3H-benzimidazole-5-carboxylic acid
SMILESCOc1ccc2c(c1)OCCn1c-2c(C2CCCCC2)c2ccc(C(=O)NC(C)(C)c3nc4ccc(C(=O)N(C)C)cc4[nH]3)cc21.COc1ccc2c(c1)OCCn1c-2c(C2CCCCC2)c2ccc(C(=O)NC(C)(C)c3nc4ccc(C(=O)O)cc4[nH]3)cc21
InChIInChI=1S/C37H41N5O4.C35H36N4O5/c1-37(2,36-38-28-16-12-24(19-29(28)39-36)35(44)41(3)4)40-34(43)23-11-14-26-30(20-23)42-17-18-46-31-21-25(45-5)13-15-27(31)33(42)32(26)22-9-7-6-8-10-22;1-35(2,34-36-26-14-10-22(33(41)42)17-27(26)37-34)38-32(40)21-9-12-24-28(18-21)39-15-16-44-29-19-23(43-3)11-13-25(29)31(39)30(24)20-7-5-4-6-8-20/h11-16,19-22H,6-10,17-18H2,1-5H3,(H,38,39)(H,40,43);9-14,17-20H,4-8,15-16H2,1-3H3,(H,36,37)(H,38,40)(H,41,42)
InChIKeyZUADMCYVQFXVDV-UHFFFAOYSA-N
MW1212.46 g/mol
LogP14.00
Rot. Bonds12

About 13-cyclohexyl-N-[2-[6-(dimethylcarbamoyl)-1H-benzimidazol-2-yl]propan-2-yl]-3-methoxy-6,7-dihydroindolo[1,2-d][1,4]benzoxazepine-10-carboxamide;2-[2-[(13-cyclohexyl-3-methoxy-6,7-dihydroindolo[1,2-d][1,4]benzoxazepine-10-carbonyl)amino]propan-2-yl]-3H-benzimidazole-5-carboxylic acid

13-cyclohexyl-N-[2-[6-(dimethylcarbamoyl)-1H-benzimidazol-2-yl]propan-2-yl]-3-methoxy-6,7-dihydroindolo[1,2-d][1,4]benzoxazepine-10-carboxamide;2-[2-[(13-cyclohexyl-3-methoxy-6,7-dihydroindolo[1,2-d][1,4]benzoxazepine-10-carbonyl)amino]propan-2-yl]-3H-benzimidazole-5-carboxylic acid (PubChem CID 162220244) has the molecular formula C72H77N9O9 and a molecular weight of 1212.46 g/mol. Its IUPAC name is 13-cyclohexyl-N-[2-[6-(dimethylcarbamoyl)-1H-benzimidazol-2-yl]propan-2-yl]-3-methoxy-6,7-dihydroindolo[1,2-d][1,4]benzoxazepine-10-carboxamide;2-[2-[(13-cyclohexyl-3-methoxy-6,7-dihydroindolo[1,2-d][1,4]benzoxazepine-10-carbonyl)amino]propan-2-yl]-3H-benzimidazole-5-carboxylic acid.

Molecular Properties

Compound Name13-cyclohexyl-N-[2-[6-(dimethylcarbamoyl)-1H-benzimidazol-2-yl]propan-2-yl]-3-methoxy-6,7-dihydroindolo[1,2-d][1,4]benzoxazepine-10-carboxamide;2-[2-[(13-cyclohexyl-3-methoxy-6,7-dihydroindolo[1,2-d][1,4]benzoxazepine-10-carbonyl)amino]propan-2-yl]-3H-benzimidazole-5-carboxylic acid
PubChem CID162220244
Molecular FormulaC72H77N9O9
Molecular Weight1212.46 g/mol
Exact Mass1211.58
IUPAC Name13-cyclohexyl-N-[2-[6-(dimethylcarbamoyl)-1H-benzimidazol-2-yl]propan-2-yl]-3-methoxy-6,7-dihydroindolo[1,2-d][1,4]benzoxazepine-10-carboxamide;2-[2-[(13-cyclohexyl-3-methoxy-6,7-dihydroindolo[1,2-d][1,4]benzoxazepine-10-carbonyl)amino]propan-2-yl]-3H-benzimidazole-5-carboxylic acid
SMILESCOc1ccc2c(c1)OCCn1c-2c(C2CCCCC2)c2ccc(C(=O)NC(C)(C)c3nc4ccc(C(=O)N(C)C)cc4[nH]3)cc21.COc1ccc2c(c1)OCCn1c-2c(C2CCCCC2)c2ccc(C(=O)NC(C)(C)c3nc4ccc(C(=O)O)cc4[nH]3)cc21
InChIInChI=1S/C37H41N5O4.C35H36N4O5/c1-37(2,36-38-28-16-12-24(19-29(28)39-36)35(44)41(3)4)40-34(43)23-11-14-26-30(20-23)42-17-18-46-31-21-25(45-5)13-15-27(31)33(42)32(26)22-9-7-6-8-10-22;1-35(2,34-36-26-14-10-22(33(41)42)17-27(26)37-34)38-32(40)21-9-12-24-28(18-21)39-15-16-44-29-19-23(43-3)11-13-25(29)31(39)30(24)20-7-5-4-6-8-20/h11-16,19-22H,6-10,17-18H2,1-5H3,(H,38,39)(H,40,43);9-14,17-20H,4-8,15-16H2,1-3H3,(H,36,37)(H,38,40)(H,41,42)
InChIKeyZUADMCYVQFXVDV-UHFFFAOYSA-N
XLogP14.00
TPSA219.95 Ų
H-Bond Donors5
H-Bond Acceptors12
Rotatable Bonds12
Heavy Atoms90
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001212.46
LogP ≤ 514.00
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1012

Analyze 13-cyclohexyl-N-[2-[6-(dimethylcarbamoyl)-1H-benzimidazol-2-yl]propan-2-yl]-3-methoxy-6,7-dihydroindolo[1,2-d][1,4]benzoxazepine-10-carboxamide;2-[2-[(13-cyclohexyl-3-methoxy-6,7-dihydroindolo[1,2-d][1,4]benzoxazepine-10-carbonyl)amino]propan-2-yl]-3H-benzimidazole-5-carboxylic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 13-cyclohexyl-N-[2-[6-(dimethylcarbamoyl)-1H-benzimidazol-2-yl]propan-2-yl]-3-methoxy-6,7-dihydroindolo[1,2-d][1,4]benzoxazepine-10-carboxamide;2-[2-[(13-cyclohexyl-3-methoxy-6,7-dihydroindolo[1,2-d][1,4]benzoxazepine-10-carbonyl)amino]propan-2-yl]-3H-benzimidazole-5-carboxylic acid?
The IUPAC name of 13-cyclohexyl-N-[2-[6-(dimethylcarbamoyl)-1H-benzimidazol-2-yl]propan-2-yl]-3-methoxy-6,7-dihydroindolo[1,2-d][1,4]benzoxazepine-10-carboxamide;2-[2-[(13-cyclohexyl-3-methoxy-6,7-dihydroindolo[1,2-d][1,4]benzoxazepine-10-carbonyl)amino]propan-2-yl]-3H-benzimidazole-5-carboxylic acid (CID 162220244) is 13-cyclohexyl-N-[2-[6-(dimethylcarbamoyl)-1H-benzimidazol-2-yl]propan-2-yl]-3-methoxy-6,7-dihydroindolo[1,2-d][1,4]benzoxazepine-10-carboxamide;2-[2-[(13-cyclohexyl-3-methoxy-6,7-dihydroindolo[1,2-d][1,4]benzoxazepine-10-carbonyl)amino]propan-2-yl]-3H-benzimidazole-5-carboxylic acid.
What is the SMILES notation for 13-cyclohexyl-N-[2-[6-(dimethylcarbamoyl)-1H-benzimidazol-2-yl]propan-2-yl]-3-methoxy-6,7-dihydroindolo[1,2-d][1,4]benzoxazepine-10-carboxamide;2-[2-[(13-cyclohexyl-3-methoxy-6,7-dihydroindolo[1,2-d][1,4]benzoxazepine-10-carbonyl)amino]propan-2-yl]-3H-benzimidazole-5-carboxylic acid?
The canonical SMILES for 13-cyclohexyl-N-[2-[6-(dimethylcarbamoyl)-1H-benzimidazol-2-yl]propan-2-yl]-3-methoxy-6,7-dihydroindolo[1,2-d][1,4]benzoxazepine-10-carboxamide;2-[2-[(13-cyclohexyl-3-methoxy-6,7-dihydroindolo[1,2-d][1,4]benzoxazepine-10-carbonyl)amino]propan-2-yl]-3H-benzimidazole-5-carboxylic acid is COc1ccc2c(c1)OCCn1c-2c(C2CCCCC2)c2ccc(C(=O)NC(C)(C)c3nc4ccc(C(=O)N(C)C)cc4[nH]3)cc21.COc1ccc2c(c1)OCCn1c-2c(C2CCCCC2)c2ccc(C(=O)NC(C)(C)c3nc4ccc(C(=O)O)cc4[nH]3)cc21.
What is the InChIKey of 13-cyclohexyl-N-[2-[6-(dimethylcarbamoyl)-1H-benzimidazol-2-yl]propan-2-yl]-3-methoxy-6,7-dihydroindolo[1,2-d][1,4]benzoxazepine-10-carboxamide;2-[2-[(13-cyclohexyl-3-methoxy-6,7-dihydroindolo[1,2-d][1,4]benzoxazepine-10-carbonyl)amino]propan-2-yl]-3H-benzimidazole-5-carboxylic acid?
The InChIKey is ZUADMCYVQFXVDV-UHFFFAOYSA-N. The full InChI is InChI=1S/C37H41N5O4.C35H36N4O5/c1-37(2,36-38-28-16-12-24(19-29(28)39-36)35(44)41(3)4)40-34(43)23-11-14-26-30(20-23)42-17-18-46-31-21-25(45-5)13-15-27(31)33(42)32(26)22-9-7-6-8-10-22;1-35(2,34-36-26-14-10-22(33(41)42)17-27(26)37-34)38-32(40)21-9-12-24-28(18-21)39-15-16-44-29-19-23(43-3)11-13-25(29)31(39)30(24)20-7-5-4-6-8-20/h11-16,19-22H,6-10,17-18H2,1-5H3,(H,38,39)(H,40,43);9-14,17-20H,4-8,15-16H2,1-3H3,(H,36,37)(H,38,40)(H,41,42).
What are the key properties of 13-cyclohexyl-N-[2-[6-(dimethylcarbamoyl)-1H-benzimidazol-2-yl]propan-2-yl]-3-methoxy-6,7-dihydroindolo[1,2-d][1,4]benzoxazepine-10-carboxamide;2-[2-[(13-cyclohexyl-3-methoxy-6,7-dihydroindolo[1,2-d][1,4]benzoxazepine-10-carbonyl)amino]propan-2-yl]-3H-benzimidazole-5-carboxylic acid?
13-cyclohexyl-N-[2-[6-(dimethylcarbamoyl)-1H-benzimidazol-2-yl]propan-2-yl]-3-methoxy-6,7-dihydroindolo[1,2-d][1,4]benzoxazepine-10-carboxamide;2-[2-[(13-cyclohexyl-3-methoxy-6,7-dihydroindolo[1,2-d][1,4]benzoxazepine-10-carbonyl)amino]propan-2-yl]-3H-benzimidazole-5-carboxylic acid has a molecular weight of 1212.46 g/mol, XLogP of 14.00, 12 rotatable bonds, 5 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for 13-cyclohexyl-N-[2-[6-(dimethylcarbamoyl)-1H-benzimidazol-2-yl]propan-2-yl]-3-methoxy-6,7-dihydroindolo[1,2-d][1,4]benzoxazepine-10-carboxamide;2-[2-[(13-cyclohexyl-3-methoxy-6,7-dihydroindolo[1,2-d][1,4]benzoxazepine-10-carbonyl)amino]propan-2-yl]-3H-benzimidazole-5-carboxylic acid is sourced from PubChem (CID 162220244), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).